68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients

被引：5

作者：

Sanli, Yasemin ^{[1
]}

Sanli, Oner ^{[3
]}

Simsek, Duygu Has ^{[4
]}

Subramaniam, Rathan M. ^{[1
,2
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Div Nucl Med, Dallas, TX USA

[2] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA

[3] Istanbul Univ, Istanbul Fac Med, Dept Urol, Istanbul, Turkey

[4] Istanbul Univ, Istanbul Fac Med, Dept Nucl Med, Istanbul, Turkey

来源：

NUCLEAR MEDICINE COMMUNICATIONS | 2018年 / 39卷 / 10期

关键词：

Ga-68-PET; MRI; Ga-68-PSMA PET; CT; high-risk prostate cancer; MEMBRANE ANTIGEN-EXPRESSION; POSITRON-EMISSION-TOMOGRAPHY; ESTRO-SIOG GUIDELINES; RADICAL PROSTATECTOMY; DIAGNOSTIC-ACCURACY; EXTRACAPSULAR EXTENSION; DISEASE RECURRENCE; LYMPH-NODES; WHOLE-BODY; THERAPY;

D O I：

10.1097/MNM.0000000000000888

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluation are important for the patient management. Recently, prostate-specific membrane antigen (PSMA)-based imaging modalities such as PSMA PET/CT and PET/MRI have received significant attention for detection of recurrent prostate cancer sites with elevated prostate-specific antigen levels, after therapy. Current evidence suggests that these imaging modalities may also have a role for the management of patients with HRPCa. In this review, we discuss PSMA-based imaging modalities in the management of patients with HRPCa.

引用

页码：871 / 880

页数：10

共 50 条

[1] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
Tulsyan, Shruti
Das, Chandan J.
Tripathi, Madhavi
Seth, Amlesh
Kumar, Rajeev
Bal, Chandrasekhar
NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
[2] 68Ga-PSMA PET-CT in patients with newly diagnosed high-risk prostate cancer
Koulikov, Victoria
Barnes, Sophie
Even-Sapir, Einat
JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[3] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
Hoffmann, Manuela A.
Wieler, Helmut J.
Baues, Christian
Kuntz, Nicholas J.
Richardsen, Ines
Schreckenberger, Mathias
UROLOGY, 2019, 130 : 1 - 12
[4] 68Ga-PSMA PET/CT in prostate cancer
Garcia Garzon, J. R.
de Arcocha Torres, M.
Delgado-Bolton, R.
Ceci, F.
Alvarez Ruiz, S.
Orcajo Rincon, J.
Caresia Aroztegui, A. P.
Garcia Velloso, M. J.
Garcia Vicente, A. M.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
[5] Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer"
Hoffmann, Manuela A.
Wieler, Helmut J.
Baues, Christian
Kuntz, Nicholas J.
Richardsen, Ines
Schreckenberger, Mathias
UROLOGY, 2019, 131 : 262 - 263
[6] 68Ga-PSMA PET/CT in Preoperative Staging of Intermediate and High Risk Prostate Cancer Patients
Schiller, C.
Beheshti, M.
Geinitz, H.
Aschacher, B.
Moinfar, F.
Broinger, G.
Pallwein-Prettner, L.
Loidl, W.
Langsteger, W.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S167 - S167
[7] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
Martin T. Freitag
Jan P. Radtke
Boris A. Hadaschik
A. Kopp-Schneider
Matthias Eder
Klaus Kopka
Uwe Haberkorn
Matthias Roethke
Heinz-Peter Schlemmer
Ali Afshar-Oromieh
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 70 - 83
[8] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
Freitag, Martin T.
Radtke, Jan P.
Hadaschik, Boris A.
Kopp-Schneider, A.
Eder, Matthias
Kopka, Klaus
Haberkorn, Uwe
Roethke, Matthias
Schlemmer, Heinz-Peter
Afshar-Oromieh, Ali
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 70 - 83
[9] 68Ga-PSMA PET/CT scan in patients with high-risk prostate cancer (PC) with ISUP grade 5
Dyankova, M.
Dancheva, Z.
Stoeva, T.
Chausheva, S.
Yordanova, T.
Chaushev, B.
Klisarova, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S507 - S507
[10] Comparison of 68Ga-PSMA PET/CT and MRI in evaluating the lateralization of prostate cancer
Wang, M.
Quan, Z.
Zhao, X.
Han, T.
Meng, X.
Kang, F.
Wang, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S495 - S495

← 1 2 3 4 5 →